• $4.9M
    Market Cap
  • -4.08%
    1-Year Change
  • Diagnostics & Research
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.03
$0.05
$0.04
1-Year Range
$0.02
$0.07
$0.04
Latest Close$0.04
Change
-$0.005 (-12.51%)
Volume135,100
Market Cap$4.9M
Shares Outstanding126.4M
P/E (TTM)-3.91
Diluted EPS (TTM)-$0.01
Enterprise Value$3.8M

Information as of 06/23/2026

Company Profile

Avricore Health Inc.
https://avricore.com
$4.9M
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
700 ? 1199 West Hastings Street, Vancouver, BC, Canada, V6E 3T5
778 968 1176

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Key Executives

  • Rodger Seccombe
  • Kiriaki Smith
  • Will Seccombe

Current Ownership Distribution

  • Other101.3M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)